Showing results (131-140 of 347) with videos related to

Sort By:
Pageof 35
The Journal of Investigative Dermatology|August 12, 2004
Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatologyMary M Prendergast, William Abramovits, Mark Boguniewicz, et al.
Journal of Drugs in Dermatology : JDD|August 20, 2019
Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis RegistryLauren Bonomo, Brian J. Abittan, Peter W. Hashim, et al.
Journal of Drugs in Dermatology : JDD|April 7, 2023
Brodalumab: 4-Year US Pharmacovigilance ReportMark Lebwohl, John Koo, Craig Leonardi, et al.
Allergy|November 30, 2022
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advancesAllen Kaplan, Mark Lebwohl, Ana M Giménez-Arnau, et al.
The British Journal of Dermatology|May 14, 2025
Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasisApril W Armstrong, Andrew Blauvelt, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|August 21, 2007
Are patients with psoriasis undertreated? Results of National Psoriasis Foundation surveyElizabeth J Horn, Kathleen M Fox, Vaishali Patel, et al.
Journal of the American Academy of Dermatology|September 1, 2025
Real-world treatment patterns in patients with generalized pustular psoriasis (GPP)Bruce Strober, Hannah Kwiatkowski, Layla Lavasani, et al.
Journal of the American Academy of Dermatology|April 18, 2015
Evaluating the economic burden of psoriasis in the United StatesJacqueline Vanderpuye-Orgle, Yang Zhao, Jackie Lu, et al.
Pageof 35